WGC Unveils Social Responsibility Report by the Gold Industry

According to the report, the pandemic has had an impact on businesses across the globe.

SEATTLE (Scrap Monster): The Gold Responsibility & Paramount Mission” summit held in Beijing on November 6th provides social responsibility report by the gold industry on prevention and control during times of crisis. The report, prepared jointly by the China Gold Association, Shanghai Gold Exchange, World Gold Council and Sina Finance, focuses on the efforts undertaken by the Chinese gold industry in overcoming the difficulties of the time.

According to the report, the pandemic has had an impact on businesses across the globe. However, all major gold companies were holding fast to the front line of epidemic prevention and control. All these companies formulated and implemented anti-epidemic measures, which helped them to resume production in a timely and regulatory manner. Also, gold regulatory bodies and industry trade associations played leading role in mobilizing the entire industry back into action.


Biden Camp Celebrates Pfizer News, Warns Masks Better Option For Fighting COVID; Novovax Gets ‘Fast Tracked’

Update (1000ET): Nobody was more relieved to see the Biden-Harris ticket prevail last week than Dr. Anthony Fauci (arguably, the first job that Biden saved was Fauci’s). Now the good doctor is joining the vaccine market pump-fest, by telling reporters that his favorite biotech company, Moderna (which he has been pumping virtually since its first vaccine-related press release) might exhibit similarly effective results to Pfizer’s vaccine.


This, despite recently released data calling the vaccine’s effectiveness into question.

* * *

Update (0910ET): Pfizer shares are now up 16% with less than a half hour to go before the open.

Meanwhile, for traders still turning over that “90% efficacy” figure (the fact that so many infections were in the placebo group is surely a good sign, the scientists said) in their heads, CNBC has offered some helpful points of comparison.https://platform.twitter.com/embed/index.html?dnt=false&embedId=twitter-widget-0&frame=false&hideCard=false&hideThread=false&id=1325802606267133953&lang=en&origin=https%3A%2F%2Fwww.zerohedge.com%2Fmarkets%2Fpfizer-biontech-trials-show-covid-19-vaccine-more-90-effective&siteScreenName=zerohedge&theme=light&widgetsVersion=ed20a2b%3A1601588405575&width=550px

Some good info on CNBC showing how great 90% effectiveness is for a vaccine. How effective current vaccines are:
Measles: 97%
Smallpox: 95%
Chicken pox: 92%
Seasonal flu: 40-60%— ForexLive (@ForexLive) November 9, 2020

Who else is ready for the ‘roaring twenties’ pt II?https://platform.twitter.com/embed/index.html?dnt=false&embedId=twitter-widget-1&frame=false&hideCard=false&hideThread=false&id=1325803021524197378&lang=en&origin=https%3A%2F%2Fwww.zerohedge.com%2Fmarkets%2Fpfizer-biontech-trials-show-covid-19-vaccine-more-90-effective&siteScreenName=zerohedge&theme=light&widgetsVersion=ed20a2b%3A1601588405575&width=550px

I wrote this yesterday

IF this vaccine works and IF we get another spending package to bridge the gap between now and ppl getting it I think 2021-2022 could see a massive boom in the economy and markets

Roaring 20s are on the tablehttps://t.co/1nLMwHLQjS pic.twitter.com/ciGMdM7xed— Ben Carlson (@awealthofcs) November 9, 2020

* * *

Update (0820ET): Adding to the positive COVID-19 vaccine news that has goosed stocks Monday morning, the FDA has officially awarded Novovax, considered a second-tier COVID-19 vaccine competitor, a “fast track” designation, while WSJ and other media are reporting that Pfizer’s vaccine could get emergency approval and head into distribution by the end of the month.